This educational activity will be designed to meet needs of U.S.-based rheumatologists, rheumatology NPs, and rheumatology PAs to improve knowledge and competence regarding the latest evidence in targeted therapies for SpA conditions and strategies for improving patient-specific, shared decision-making care to advance the optimal outcomes of patients with these debilitating conditions. Learn more about the clinical manifestations of Spondyloarthritis (SpA) conditions to enable prompt differentiation and diagnosis; apply the latest clinical evidence for IL-17 antagonists for the management of SpA conditions; and develop strategies to optimize shared decision-making efforts and collaboration across the multidisciplinary care team in the management of SpA conditions. Developed and offered by Med Learning Group, Supported by Lilly.
